Given that many interacting partners in the HMGA2 pathway, including up- and downstream genes IGF2BP2, LIN28 and let-7 have been elucidated, they serve as attractive targets whose modulation could be curative for many cancers involving the HMGA2 pathway. This evidence concerns the gene HMGA2 and cancer.